Navigation Links
Touch Bionics appoints Head of Clinical Advocacy
Date:4/2/2008

Experienced industry professional hired to promote clinical awareness,

support and partnerships in the U.S.

BOSTON, MA and LIVINGSTON, Scotland, April 2 /PRNewswire/ - Touch Bionics, developer of the i-LIMB Hand, the world's first commercially available bionic hand with articulating fingers, today announced that it has hired Karl Lindborg, CPO, as the company's Head of Clinical Advocacy.

Effective immediately, Lindborg will operate out of California, further strengthening Touch Bionics' U.S. presence, with the company having recently expanded its sales, marketing, and support teams in the country.

As head of clinical advocacy, Lindborg's role will be to provide clinical direction for the company in the areas of education and association relations, clinical compatibility of upper extremity systems, as well as public forums and clinical symposia. In addition, Lindborg will be the direct conduit into the company for the clinical community regarding questions, concerns and technical support. He will also support Touch Bionics' product development activities.

"I am particularly impressed with the numerous anatomical degrees of freedom the i-LIMB Hand offers over other hands on the market today. This is what functionality is all about," said Lindborg. "The i-LIMB Hand offers a level of flexibility and dexterity previously unavailable to the patient, Certified Prosthetist or Occupational Therapist working with upper extremity limb deficiencies. I look forward to being a member of the Touch Bionics team and clinically supporting its revolutionary products to fellow prosthetic clinicians and their patient population."

Lindborg has more than a decade of experience as a clinician in the orthotics and prosthetics business, holding a variety of clinical and administrative positions in private clinical setting as well as public institutional settings. Mr. Lindborg is also very active with various political, technological and product development roles. Most recently, he was employed with the Department of Veteran Affairs as Chief of VA Northern California Health Care System's Prosthetic and Orthotic Laboratory. Lindborg holds a Bachelor of Science degree in orthotics and prosthetics from the University of Washington School of Rehabilitation Medicine.

About Touch Bionics

Touch Bionics is a leading developer of advanced upper-limb prosthetics. In 2007, Touch Bionics brought to market the i-LIMB Hand, a first-to-market prosthetic device with five individually powered digits. The company continues to develop leading-edge technologies for the treatment of patients with upper-limb deficiencies. For more information, visit http://www.touchbionics.com

The names of actual companies or products mentioned herein may be the

trademarks of their respective owners.


'/>"/>
SOURCE TOUCH BIONICS
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
2. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
3. Touch Bionics expands U.S. presence to meet demand for i-LIMB Hand
4. Touch Bionics adds to sales, marketing, production and design teams
5. China Technology Appoints Deloitte Touche Tohmatsu CPA as Independent Auditor
6. Care to Care Begins Providing Radiology Benefit Management Services to Touchstone Health
7. Touch Bionics signs U.S. distribution agreement with SPS
8. Encision Launches Next Generation of EnTouch(R) Handles for Advanced Laparoscopic Procedures
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
11. Codexis Appoints Singapore Laboratories Managing Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... June 28, 2017 Michael Zasloff , ... University School of Medicine, and Founder, Chairman and CEO ... study that has helped clarify the function of alpha-Synuclein ... other neurodegenerative diseases. Denise Barbut , MD, FRCP, ... was senior co-author of the study. Published ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... three research projects accepted for presentation at the 33rd Annual Meeting of the ... – including some of the world’s top thought leaders in reproductive medicine – ...
(Date:6/28/2017)... and London, June 28, 2017 (PRWEB) , ... ... ... The latest release of Siemens’ STAR-CCM+® software for multiphysics computational fluid ... enable automated product design exploration and optimization. STAR-CCM+ version 12.04 introduces Design ...
(Date:6/28/2017)... NC (PRWEB) , ... June 28, 2017 , ... Studies ... might lead to an effective treatment for Parkinson’s disease. But what has not been ... should take place to gain the best results. , A new study coming out ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
(Date:3/23/2017)... , Mar. 23, 2017 Research and Markets ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 8.8% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):